823 related articles for article (PubMed ID: 29908540)
1. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
[TBL] [Abstract][Full Text] [Related]
3. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
[TBL] [Abstract][Full Text] [Related]
4. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
Donohue JF; Herje N; Crater G; Rickard K
Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
6. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
[TBL] [Abstract][Full Text] [Related]
7. Investigating Fractional Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review.
Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
COPD; 2018; 15(4):377-391. PubMed ID: 30067401
[TBL] [Abstract][Full Text] [Related]
8. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
[TBL] [Abstract][Full Text] [Related]
9. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
10. Role of pulmonary function and FeNO detection in early screening of patients with ACO.
Wang J; Wang W; Lin H; Huan C; Jiang S; Lin D; Cao N; Ren H
Exp Ther Med; 2020 Aug; 20(2):830-837. PubMed ID: 32742326
[TBL] [Abstract][Full Text] [Related]
11. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
12. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
13. Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation.
Tang B; Huang D; Wang J; Luo LL; Li QG
Med Sci Monit; 2020 Mar; 26():e921182. PubMed ID: 32161254
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.
Guo Y; Hong C; Liu Y; Chen H; Huang X; Hong M
Medicine (Baltimore); 2018 Jun; 97(23):e10857. PubMed ID: 29879019
[TBL] [Abstract][Full Text] [Related]
15. Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study.
Çolak Y; Afzal S; Nordestgaard BG; Marott JL; Lange P
Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29903861
[TBL] [Abstract][Full Text] [Related]
16. [Fractional exhaled nitric oxide in bronchial inflammatory lung diseases].
Xia Q; Pan P; Wang Z; Lu R; Hu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):365-70. PubMed ID: 24820276
[TBL] [Abstract][Full Text] [Related]
17. [Value of Fractional Exhaled Nitric Oxide after Using a Beta-2 Bronchodilator in the Differential Diagnosis of Bronchial Asthma and Chronic Obstructive Pulmonary Disease].
Ura M; Tanaka H; Takahashi K; Yamazaki H; Fujimoto K
Rinsho Byori; 2016 Feb; 64(2):127-32. PubMed ID: 27311275
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.
Katoh S; Ikeda M; Shirai R; Abe M; Ohue Y; Kobashi Y; Oka M
J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604
[TBL] [Abstract][Full Text] [Related]
19. Association between fractional exhaled nitric oxide (FeNO) cutoff values (25 ppb) and risk factors of cough.
Qian L; Pan S; Shi J; Du Y; Huang Q; Jie Z
Clin Respir J; 2018 Jan; 12(1):193-199. PubMed ID: 27249415
[TBL] [Abstract][Full Text] [Related]
20. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
